Literature DB >> 15520644

Conference report--gene therapy and lung cancer--no time to wait.

Sara M Mariani1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15520644      PMCID： PMC1435636     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  21 in total

1.  Intratumoral therapy with cytokine gene-modified dendritic cells in murine lung cancer models.

Authors:  Sherven Sharma; Seok Chul Yang; Raj K Batra; Steven M Dubinett
Journal:  Methods Mol Med       Date:  2003

Review 2.  Advances in the treatment of malignant pleural mesothelioma.

Authors:  D H Sterman; L R Kaiser; S M Albelda
Journal:  Chest       Date:  1999-08       Impact factor: 9.410

Review 3.  Gene therapy for lung neoplasms.

Authors:  Steven M Albelda; Rainer Wiewrodt; Daniel H Sterman
Journal:  Clin Chest Med       Date:  2002-03       Impact factor: 2.878

4.  Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo.

Authors:  S Sharma; M Stolina; J Luo; R M Strieter; M Burdick; L X Zhu; R K Batra; S M Dubinett
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

5.  Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion.

Authors:  G W Pien; M J Gant; C L Washam; D H Sterman
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

6.  Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

Authors:  Joan H Schiller; David Harrington; Chandra P Belani; Corey Langer; Alan Sandler; James Krook; Junming Zhu; David H Johnson
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

7.  Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.

Authors:  M Odaka; D H Sterman; R Wiewrodt; Y Zhang; M Kiefer; K M Amin; G P Gao; J M Wilson; J Barsoum; L R Kaiser; S M Albelda
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

8.  Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector.

Authors:  H Sauthoff; S Heitner; W N Rom; J G Hay
Journal:  Hum Gene Ther       Date:  2000-02-10       Impact factor: 5.695

Review 9.  Emerging new therapies for chemotherapy-resistant cancer using adenoviral vectors.

Authors:  John Nemunaitis; Casey Cunningham
Journal:  Drug Resist Updat       Date:  2002-02       Impact factor: 18.500

10.  Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points.

Authors:  Harald Sauthoff; Jing Hu; Cielo Maca; Michael Goldman; Sheila Heitner; Herman Yee; Teona Pipiya; William N Rom; John G Hay
Journal:  Hum Gene Ther       Date:  2003-03-20       Impact factor: 5.695
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.